ES2107793T3 - Ciclo- y bicicloalquenos antiandrogenicos. - Google Patents

Ciclo- y bicicloalquenos antiandrogenicos.

Info

Publication number
ES2107793T3
ES2107793T3 ES94901162T ES94901162T ES2107793T3 ES 2107793 T3 ES2107793 T3 ES 2107793T3 ES 94901162 T ES94901162 T ES 94901162T ES 94901162 T ES94901162 T ES 94901162T ES 2107793 T3 ES2107793 T3 ES 2107793T3
Authority
ES
Spain
Prior art keywords
compounds
androgen
image
carbons
metabolism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94901162T
Other languages
English (en)
Spanish (es)
Inventor
Larry C Ford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cosmos Pharmaceutical Corp USA
Original Assignee
Cosmos Pharmaceutical Corp USA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cosmos Pharmaceutical Corp USA filed Critical Cosmos Pharmaceutical Corp USA
Application granted granted Critical
Publication of ES2107793T3 publication Critical patent/ES2107793T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/06Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
    • C07C403/10Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by etherified hydroxy groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/128Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by alcoholysis
    • C07C29/1285Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by alcoholysis of esters of organic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/06Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
    • C07C403/08Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C07C49/733Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having two rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/743Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185Saturated compounds having only one carboxyl group and containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/007Esters of unsaturated alcohols having the esterified hydroxy group bound to an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/013Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Steroid Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polymerisation Methods In General (AREA)
  • Liquid Crystal Substances (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ES94901162T 1993-01-15 1993-10-14 Ciclo- y bicicloalquenos antiandrogenicos. Expired - Lifetime ES2107793T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08004972 US5264619B1 (en) 1993-01-15 1993-01-15 Anti-androgenic cyclo and bicyclo alkenes

Publications (1)

Publication Number Publication Date
ES2107793T3 true ES2107793T3 (es) 1997-12-01

Family

ID=21713473

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94901162T Expired - Lifetime ES2107793T3 (es) 1993-01-15 1993-10-14 Ciclo- y bicicloalquenos antiandrogenicos.

Country Status (21)

Country Link
US (1) US5264619B1 (enrdf_load_stackoverflow)
EP (1) EP0679152B1 (enrdf_load_stackoverflow)
JP (1) JPH08505851A (enrdf_load_stackoverflow)
KR (1) KR960700213A (enrdf_load_stackoverflow)
CN (1) CN1051758C (enrdf_load_stackoverflow)
AT (1) ATE157342T1 (enrdf_load_stackoverflow)
AU (1) AU672265B2 (enrdf_load_stackoverflow)
BR (1) BR9307758A (enrdf_load_stackoverflow)
CA (1) CA2152588C (enrdf_load_stackoverflow)
DE (1) DE69313466T2 (enrdf_load_stackoverflow)
DK (1) DK0679152T3 (enrdf_load_stackoverflow)
ES (1) ES2107793T3 (enrdf_load_stackoverflow)
GR (1) GR3025092T3 (enrdf_load_stackoverflow)
IL (1) IL107699A0 (enrdf_load_stackoverflow)
MX (1) MX9307235A (enrdf_load_stackoverflow)
MY (1) MY109679A (enrdf_load_stackoverflow)
NO (1) NO952787L (enrdf_load_stackoverflow)
PH (1) PH30285A (enrdf_load_stackoverflow)
TW (1) TW294656B (enrdf_load_stackoverflow)
WO (1) WO1994015900A1 (enrdf_load_stackoverflow)
ZA (1) ZA938767B (enrdf_load_stackoverflow)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4311870C2 (de) * 1993-04-10 1998-07-30 Altramed Holdings Ltd Verwendung eines Anti-Östrigens zur Therapie und Prophylaxe von Demenz-Erkrankungen
DE4320896A1 (de) * 1993-06-24 1995-01-05 Denecke Rainer Dr Med Vet Präparat zur Therapie und Prophylaxe von Demenz-Erkrankungen
AU6482596A (en) 1995-07-03 1997-02-05 Wilson T. Crandall Transdermal and oral treatment of androgenic alopecia
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
KR20010052502A (ko) * 1998-06-03 2001-06-25 다니엘 피. 맥컬럼 N-헤테로사이클릭 카복실산 및 카복실산 등입체의 요소및 카르밤산염
EP1084106A1 (en) 1998-06-03 2001-03-21 GPI NIL Holdings, Inc. N-linked sulfonamides of heterocyclic carboxylic acids or carboxylic acid isosteres
US7253169B2 (en) 1999-11-12 2007-08-07 Gliamed, Inc. Aza compounds, pharmaceutical compositions and methods of use
US6417189B1 (en) 1999-11-12 2002-07-09 Gpi Nil Holdings, Inc. AZA compounds, pharmaceutical compositions and methods of use
DE60026568D1 (de) 1999-12-21 2006-05-04 Mgi Gp Inc Hydantoin derivate, pharmazeutische zusammensetzungen und verfahren zu ihrer verwendung
IL162849A0 (en) * 2002-01-09 2005-11-20 Trident Sciences Llc Compounds for blocking androgen receptors
US20070048246A1 (en) * 2005-09-01 2007-03-01 Biophysica Research, Inc. Novel skin care compositions
US20110021869A1 (en) * 2009-07-24 2011-01-27 Hilary John Cholhan Single-incision minimally-invasive surgical repair of pelvic organ/vaginal prolapse conditions
US8410314B1 (en) 2010-06-21 2013-04-02 Bcs Business Consulting Services Pte Ltd. Method of synthesis
SG11201507157YA (en) * 2013-03-11 2015-10-29 Bcs Business Consulting Services Pte Ltd Method of synthesis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO742181L (enrdf_load_stackoverflow) * 1973-06-20 1975-01-13 Scherico Ltd
US4689345A (en) * 1982-05-06 1987-08-25 Cbd Corporation Oxygenated alkyl substituted bicyclo alkanes
US4535182A (en) * 1982-08-26 1985-08-13 Sumitomo Chemical Company, Limited Process for preparing 2-cyclopentenone esters
GB8406000D0 (en) * 1984-03-07 1984-04-11 Ici Plc Olefine derivatives
JPH0637388B2 (ja) * 1986-02-17 1994-05-18 千寿製薬株式会社 水性液剤
US4963583A (en) * 1987-10-05 1990-10-16 Ciba-Geigy Corporation Beta-ionone derivatives as antifungal agents
JP2608089B2 (ja) * 1988-03-09 1997-05-07 帝人株式会社 4−ヒドロキシ−2−シクロペンテノン類およびそれを含有する薬剤組成物
US5010105A (en) * 1989-06-09 1991-04-23 Merck & Co., Inc. Antihypercholesterolemic compounds

Also Published As

Publication number Publication date
CA2152588C (en) 1998-05-05
KR960700213A (ko) 1996-01-19
GR3025092T3 (en) 1998-01-30
WO1994015900A1 (en) 1994-07-21
US5264619A (en) 1993-11-23
ZA938767B (en) 1994-06-30
CN1091733A (zh) 1994-09-07
DE69313466T2 (de) 1998-04-02
EP0679152B1 (en) 1997-08-27
PH30285A (en) 1997-02-20
MX9307235A (es) 1994-07-29
ATE157342T1 (de) 1997-09-15
NO952787L (no) 1995-09-01
DE69313466D1 (en) 1997-10-02
DK0679152T3 (da) 1998-02-23
IL107699A0 (en) 1994-02-27
US5264619B1 (en) 1996-05-14
BR9307758A (pt) 1995-10-24
JPH08505851A (ja) 1996-06-25
EP0679152A1 (en) 1995-11-02
CA2152588A1 (en) 1994-07-21
NO952787D0 (no) 1995-07-13
TW294656B (enrdf_load_stackoverflow) 1997-01-01
MY109679A (en) 1997-04-30
AU5584794A (en) 1994-08-15
CN1051758C (zh) 2000-04-26
AU672265B2 (en) 1996-09-26

Similar Documents

Publication Publication Date Title
US5264619B1 (en) Anti-androgenic cyclo and bicyclo alkenes
EA200100202A1 (ru) 4-карбоксиамино-2-замещенные-1,2,3,4-тетрагидрохинолины в качестве сетр-ингибиторов
KR920014766A (ko) 화장제 조성물
MY111178A (en) Antitumor compositions and methods of treatment
PT99135A (pt) Processo para a preparacao de derivados de piperazina
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
EP0772673A4 (en) METHOD FOR PRODUCING SOAP BARS WITH A HIGH HUMIDITY CONTENT
BR8700464A (pt) Processo para reticulacao de organopolissiloxanas e composicao para execucao do processo
RU95103438A (ru) Фторированное производное витамина d3
ES2104177T3 (es) Analogos noveles de la vitamina d.
NO156370C (no) AnalogifremgangsmŸte ved fremstilling av terapeutisk virksomme polyolefiniske-alfa-alkyl-carboxylsyrer.
JPS56104834A (en) Anthracenone compound
JPS57501850A (enrdf_load_stackoverflow)
ES2062442T3 (es) Nuevos derivados de tetrahidro-5,6,7,8 naftalenol-1, su procedimiento de preparacion y su utilizacion como agentes antioxidantes en composiciones cosmeticas y farmaceuticas que los contienen.
AR016733A1 (es) Procedimiento de preparacion de 4-(3-piridinil)-1h-imidazol, y los compuestos intermedios empleados
ES2062792T3 (es) Acidos dihidrobenzopiran-2-carboxilicos alcoxi-sustituidos y derivados de los mismos.
PE42998A1 (es) Derivados 1,25-dihidroxi-16,22,23-tridehidro-colecalciferol
SE8004621L (sv) Bensimidazolderivat
ES2028963T3 (es) Procedimiento para la obtencion de dien-1-oles, 9-hidroxidodec-10-enil-1-terc.-butileter y su empleo como producto intermedio para la sintesis de 8,10-dodecadienol.
KR940005807A (ko) 가죽과 모피의 타닝 방법
ES501744A0 (es) Procedimiento para la obtencion de bis (fenoxiacetatos sus- tituidos)de n-alcohil-dialcanolaminas

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 679152

Country of ref document: ES